Merkel Cell Carcinoma Program
855-776-4224
Call the Mass General Brigham Cancer Institute at 855-776-4224
International leaders in caring for Merkel cell carcinoma
Merkel cell carcinoma is a rare, aggressive skin cancer that most often develops on sun-exposed skin. Without specialized care, it can spread quickly.
Patients from around the world seek our oncologists and surgeons for their expertise in diagnosing and treating this disease. From research to clinical care, we are international leaders in diagnosing and treating this rare skin cancer. You will have access to the most advanced treatments and specialists ready to deliver the personalized care you need.
Our approach to care for Merkel cell carcinoma
Our surgeons bring extensive experience in treating skin cancers. When surgery is needed, they use advanced, minimally invasive techniques to safely remove cancer while preserving as much healthy tissue as possible and minimizing scarring.
These approaches may include sentinel lymph node biopsy to track whether cancer has spread, and, in some cases, index node excision after neoadjuvant therapy.
Our radiation oncologists are among the best in the world at precision therapies that spare healthy tissue. These methods create 3D maps of tumors to guide targeted treatments:
- Intensity modulated radiation therapy adjusts beam strength for tumor areas based on their distance from normal tissues.
- Volumetric modulated arc radiotherapy adjusts beam strength according to the thickest areas of the tumor.
Our medical oncologists offer innovative approaches, including immune-stimulating medications and chemotherapeutic medications that shrink early tumors.
Our specially trained team also provides personal attention and advice on coping with side effects of medications for cancer.
Expert treatment for Merkel cell carcinoma
Our cancer specialists
855-776-4224
Call the Mass General Brigham Cancer Institute
Cancer clinical trials and research
Explore our cancer research
Learn how cancer research informs patient care
Search clinical trials
Patient resources and support
View all patient resources
Contact the Cancer Institute
855-776-4224
Call the Mass General Brigham Cancer Institute at 855-776-4224
International Patient Services
Contact International Patient Services